患者抗凝血因子Ⅷ药物抗体优先结合凝血因子Ⅷ共价状态的一个亚群
研究采用差异半胱氨酸烷基化与质谱法测定人血及重组凝血因子Ⅷ的8对二硫键氧化还原状态,发现约10%至约70%的分子中8对二硫键均未形成,并评估5种患者来源抗凝血因子Ⅷ抗体与该二硫键状态群的结合,发现5种抗体均优先结合8对二硫键中2或3对显著更未形成的凝血因子Ⅷ状态。
要点
- 约10%至约70%的凝血因子Ⅷ分子中8对二硫键均未形成。
- 5种患者抗凝血因子Ⅷ抗体均优先结合特定二硫键更未形成的凝血因子Ⅷ状态。
- 优先结合状态涉及A3域C1918-C1922、C1域C2040-C2188及C2域C2193-C2345。
核心结论
- 患者抗凝血因子Ⅷ药物抗体优先结合8对二硫键中2或3对显著更未形成的凝血因子Ⅷ状态亚群,该亚群具有利于抗药物抗体结合的长程构象动态性。
研究设计与样本
- 采用差异半胱氨酸烷基化与质谱法测定人血及重组凝血因子Ⅷ的8对二硫键氧化还原状态,并评估5种患者来源抗凝血因子Ⅷ抗体与凝血因子Ⅷ二硫键状态群的结合,结合二硫键诱变实验与分子动力学模拟。
主要发现
- 人血及重组凝血因子Ⅷ中8对二硫键在约10%至约70%的分子中均未形成。
- 5种患者来源抗凝血因子Ⅷ抗体均优先结合8对二硫键中2或3对显著更未形成的凝血因子Ⅷ状态,涉及A3域C1918-C1922、C1域C2040-C2188及C2域C2193-C2345。
- 二硫键诱变实验与分子动力学模拟提示该凝血因子Ⅷ状态亚群具有利于抗药物抗体结合的长程构象动态性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hemophilia A is a chronic life-threatening condition caused by the deficiency or dysfunction of plasma coagulation factor VIII (FVIII) and commonly managed by prophylaxis with regular infusion of FVIII protein. A major obstacle to FVIII replacement therapy is the generation of alloantibodies that diminish efficacy. Disulfide bonds link pairs of cysteine residues in proteins and, in several proteins, have been found to be only partially formed in the mature proteins. FVIII contains 8 disulfide bonds and their redox state in human blood and recombinant FVIII was determined using differential cysteine alkylation and mass spectrometry. All 8 disulfide bonds were found to be unformed in ∼10% to ∼70% of molecules of FVIII populations, which suggested a conformational flexibility that could favor the binding of certain ligands to subsets of FVIII with more or less formed disulfide bonds. To test this hypothesis, the binding of a panel of 5 patient-derived anti-FVIII antibodies to the population of FVIII disulfide-bonded states was evaluated. All 5 antibodies bound preferentially to FVIII states in which 2 or 3 of the 8 disulfides are significantly more unformed: C1918-C1922 in the A3 domain, C2040-C2188 in the C1 domain, and C2193-C2345 in the C2 domain. Disulfide bond mutagenesis experiments and molecular dynamics simulations indicate that this subset of FVIII states has long-range conformational dynamism that favors antidrug antibody binding. These findings will assist efforts to engineer an FVIII molecule that is less prone to neutralization by antidrug antibodies and has general implications for autoimmune conditions and antibody drug efficacy.
引用
- Butera D, Pijning AE, Avery NG, et al. Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states. Blood Adv. 2025. PMID: 40203231. doi:10.1182/bloodadvances.2025016474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。